跳转至内容
Merck
CN

C5VP001A

Cellicon®过滤器组件,带Durapore®

filtration area 0.01 m2

别名:

Cellicon®灌注过滤器,带Durapore®

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
42294704
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Cellicon®过滤器组件,带Durapore®膜, filtration area 0.01 m2

material

PET support
PVDF
polyester support

agency

meets USP Biological Reactivity Test for class VI plastics (family component materials)

sterility

sterile; γ-irradiated (level of 25-40kGy)

flow rate measuring range

10 L/min (/m2)

parameter

1 psi max. reverse press. exposure at 25 °C
1-2.5 L process volume
15 psi at 25 °C (max. burst pressure)
5 psi max. inlet pressure at 25 °C

filtration area

0.01 m2

membrane filtration area

0.01 m2

pore size

5 μm pore size

storage temp.

15-25°C

Quality Level

正在寻找类似产品? 访问 产品对比指南

Application

微量过滤
种子灌注

Features and Benefits

高处理量。可预测的线性扩展,从实验室到生产规模。可靠和可重复的性能。低横流和细胞剪切。

General description

Cellicon®灌注过滤器设计用于满足灌注种子培养挑战。它是一个平板细胞保留过滤器,作为一次性组件的一部分,在切向流过滤模式下运行。灌注操作提供高密度细胞培养物,减轻了处理大量生产生物反应器的负担,同时增加了制造灵活性。在种子序列中引入灌注可以为一个或多个生产生物反应器灌输更多数量的细胞,从而提高流程效率。
外壳/套模/装配配件/一次性泵头: 聚丙烯;进料屏幕:聚对苯二甲酸乙二醇酯(PET);聚酯纤维;油管:AdvantaFlex(热塑性弹性体),DOW Pharma 65;进料屏幕:聚对苯二甲酸乙二醇酯(PET);聚酯纤维;压力传感器:聚砜;尼龙扎带:尼龙

Other Notes

这些产品是在遵守良好生产规范的工厂中生产的。

Legal Information

CELLICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Durapore is a registered trademark of Merck KGaA, Darmstadt, Germany

法规信息

新产品
此项目有

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

商品

How the Cellicon® filter and controller enables seamless adoption of a perfused N-1 seed train step into the cell expansion process.

Before adoption of single-use technologies in biomanufacturing, manufacturers must assess the risk to the drug product from potential leachables. This article highlights a general approach based on the United States Pharmacopeia (USP).

Cellvento 4CHO-X Expansion Medium enhances cell biomass for bioreactor inoculation in cell expansion stages.

This page describes the financial and operational advantages offered by the Cellicon® Cell Retention Device in an N-1 perfusion process at the 2,000 L scale in comparison to a cell retention device from another supplier.

查看所有结果

相关内容

Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.

Biopharmaceutical developers need efficient, productive upstream processes that deliver high quality monoclonal antibodies (mAbs) and other types of recombinant proteins. Process intensification can future-proof their manufacturing strategies, reduce costs, and increase facility flexibility.

了解有关 mAB 生物反应器生产以及该步骤所需产品的更多信息。

Learn more on mAB bioreactor production, and the products you need for this step.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持